Washington, DC 20006-5349
HELPLINE
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
Moderated by Daniel Sterman, MD, this panel of mesothelioma patients who underwent an EPP (extrapleural pneumonectomy — lung removal) discuss their experience and side-effects prior
This “Fundraising for the Foundation” panel discusses their Fundraise for Meso events, best practices, and answered questions from moderator Katie Jamieson, co-chair of the Community
The Mesothelioma Applied Research Foundation hosted its 2020 Awards Program on Facebook Live Sunday, Nov. 22 at 9:00 PM ET. The virtual program recognized the
Andreas Rimner, MD discusses a phase 3 clinical trial that is testing the addition of IMRT (intensity-modulated radiotherapy) to pemetrexed (Alimta)/platinum based therapy for pleural
Sean Drake, MD provides an overview of vaccinations — tetanus, diphtheria and pertussis, hepatitis A, hepatitis B, pneumonia, pneumovax, prevnar 13, shingles, shingrix, influenza (flu),
To honor her 11-year “cancerversary,” Ivana Mihajlovic, a 41-year-old peritoneal mesothelioma warrior, is hosting a Fundraise for Meso event on Saturday, Nov. 21 in Kensington,
Arkadiusz Dudek, MD, PhD, discusses the Phase 2 Nivolumab (Opdivo) + Ramucirumab clinical trial for previously-treated mesothelioma patients. The study is available at Moffitt Cancer
Dr. Paul Sugarbaker joins us for an interview about HIPEC (hyperthermic intraperitoneal chemotherapy) for peritoneal mesothelioma. Paul Sugarbaker, MD, FACS, FRCS, is the Chief of